Services
Axela Biosciences is specialized in providing CRO services in discovery biology and translational development, two interconnected phases of biomedical research that drive the progression of scientific knowledge into real-world medical applications.
Discovery biology focuses on understanding the fundamental biological processes that govern cellular function, disease mechanisms, and organismal development. This phase involves basic research, such as identifying molecular pathways, characterizing disease biomarkers, and unraveling the genetic and environmental factors that contribute to health and disease.
Translational development, on the other hand, takes these findings and applies them to create tangible medical solutions. This involves translating basic scientific discoveries into potential therapeutic interventions, such as drug candidates, diagnostic tools, or personalized medicine strategies. It encompasses preclinical research, clinical trials, and regulatory approval, with the goal of moving discoveries from the laboratory to clinical settings where they can improve patient care.
Axela Biosciences seamlessly integrate discovery biology and translational development to accelerate the transition of novel ideas into actionable treatments, enhancing our clients’ ability to address complex diseases and improve human health.
Browse Our Services by

​
Comprehensive Platforms for Drug Discovery and Translational Development
-
Small Molecule Drug Discovery: We offer specialized bioassay platforms for screening and characterizing small molecule therapeutics, such as kinase inhibitors, targeted protein degraders (TPDs), and other innovative modalities.
-
Large Molecule Drug Discovery: Our extensive capabilities support the development of antibodies, antibody-drug conjugates (ADCs), and other biologics.
-
Cell and Gene Therapies: We provide advanced bioassay solutions for characterizing cell and gene therapies, including CAR-T cells, iPSCs, and miRNA therapeutics.
​
Advanced Analytical Technologies for Biomarker Discovery and Validation
-
Bioanalysis and Biomarker Analysis: Our state-of-the-art bioanalytical laboratories offer comprehensive services for PK/PD, immunogenicity assessment, and biomarker analysis, utilizing cutting-edge technologies such as flow cytometric analysis, automatic western blot, and ELISA.
-
Ultrasensitive, Multiplex or Homogeneous Immunoassays: We develop and implement various formats of immunoassays with exceptional sensitivity and specificity to quantify multiple analytes simultaneously.
-
Spatial Biology, nCounter Genomics, QuantiGene Assays and Proteomics: Our spatial biology platforms enable the analysis of complex tissue microenvironments, uncovering novel insights into disease mechanisms, drug responses, as well as patient stratification.
​
Therapeutic Focuses and Service Areas
-
Oncology: We offer a comprehensive range of cancer-focused bioassays, covering target identification, SAR screening, efficacy evaluation, combination strategy, and biomarker discovery.
-
Immunology: Our immunology expertise provides series of bioassays for evaluating immune cell function, cytokine profiling, and immune checkpoint modulation for the applications in immuno-oncology, inflammation and autoimmune diseases.
-
Hematology: We provide specialized bioassays for hematological disorders, including hematological malignancies.
-
Neurology: Our neurology bioassays cover neurodegenerative diseases, neuroinflammation, and neurotransmitter signaling.
-
Additional Areas: We also offer comprehensive support clients in the fields of cosmetics, fragrance, botanicals, agri-biotechnology, and stem cell research.​